UNSPSC 51373467: Guaifenesin/hydrocodone/phenylpropanolamine/salicylamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373467 Guaifenesin/hydrocodone/phenylpropanolamine/salicylamide is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The two recent opportunities tagged to this code do not track the specific combination of active pharmaceutical ingredients the code names; instead, they solicit naloxone and drug deactivation systems (Seminole County, Florida) and generic multi-source pharmaceuticals and OTC products broadly (Minnesota Multistate Cooperative Purchasing Alliance). The mismatch suggests either inconsistent code assignment by the issuing agencies or that this code sees little active purchasing activity in the state and local market. When opportunities do appear under this code, they reflect standard pharmaceutical procurement — competitive bidding for stock quantities with requirements for FDA compliance, current Good Manufacturing Practices certification, Drug Supply Chain Security Act adherence, and delivery through authorized wholesalers.

Issuing bodies engaging in pharmaceutical procurement at the state and local level include county health departments (Seminole County) and state cooperative purchasing alliances (Minnesota Department of Administration via MMCAP). The Seminole County IFB (IFB60459723LAS, response due July 26, 2026) sought annual quantities of naloxone and drug deactivation systems with quarterly deliveries and a two-year initial contract term. The MMCAP RFP (S1070000015802, response due March 26, 2026) established multi-award contracts for generic pharmaceuticals across participating state and local facilities in Minnesota and Oregon, effective July 1, 2026, with vendor compensation structured as fixed pricing (10 percent evaluation weight) and price competitiveness (75 percent weight). Recent activity is concentrated in the Southeast (Florida) and Upper Midwest (Minnesota, Oregon), though the sparse, code-mismatched opportunity set suggests limited or irregular purchasing under this specific commodity.